Disphar is specialized in the Europe-wide industrial commercialization of generic products.
Part of these products originate from Disphar partners within and outside Europe who desire to benefit from Disphar’s good reputation, broad customer base and specialized expertise with respect to industrial commercialization of generic products in Europe. Disphar offers to them the ideal set-up to address successfully all crucial elements necessary to upgrade, register and license out (generic) pharmaceutical products throughout Europe.
Within such partnerships, Disphar takes care of specialized activities like dossier conversion into EU eCTD format, registration in commercially attractive EU markets, pre-financing of regulatory fees, closure of sub-licensing deals including long-term supply agreements, supply logistics, QA support and financial handling. All in close consultation with the partner concerned.
If you are interested in learning more about how Disphar can generate additional business for you in Europe, please feel free to contact Mr Wolter Kuizinga, Director Strategic Business Affairs.
